SCHEMBL4973221

SCHEMBL4973221

CC(c1ccccc1)C1CCC1(NC(N)=O)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.38
KCNQ3 O43525 1/20 0.38
KCNQ2 O43526 1/20 0.38
KCNQ4 P56696 1/20 0.38
KCNQ5 Q9NR82 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HPGD P15428 3/20 0.37
LMNA P02545 3/20 0.37
GAA P10253 1/20 0.37
EPHX2 P34913 1/20 0.37
ALOX5 P09917 1/20 0.36
EPHX1 P07099 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
BCAT2 O15382 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4560519 0.74 OPRL1 (0.41) ALOX5
SCHEMBL3387663 0.72 ALOX5 (0.42) RECQLKMT2AHPGDLMNAEPHX2
SCHEMBL4862036 0.70 KMT2A (0.39) RECQLKMT2AHPGDLMNAEPHX1
SCHEMBL17320338 0.69 CYP3A4 (0.43) KMT2AHPGDLMNAEPHX2CYP3A4
SCHEMBL4558510 0.69 OPRL1 (0.39) KMT2AHPGDLMNAEPHX1CYP3A4
SCHEMBL4558688 0.68 SLC6A2 (0.45) ALOX5CYP2D6
SCHEMBL9023093 0.67 L3MBTL1 (0.38) GAA
SCHEMBL4973208 0.67 MEN1 (0.39) RECQLKCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL17311744 0.63 CYP2D6 (0.39) MEN1KMT2AHPGDLMNAGAA
SCHEMBL17311743 0.63 CYP2D6 (0.39) MEN1KMT2AHPGDLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1954668-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS Brystol-Myers Squibb Company (US) 2008-08-13 EP disclosed
WO-2007062308-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 WO disclosed